Health
Steatotic liver disease risk scores compared for predicting cirrhosis
For patients with steatotic liver disease (SLD), the steatosis-associated fibrosis estimator (SAFE) score demonstrated the greatest net benefit for predicting cirrhosis, according to a study published online Sept. 21 in JAMA Internal…
AI Summary
A study published online Sept. 21 in JAMA Internal Medicine found that, among patients with steatotic liver disease, the steatosis‑associated fibrosis estimator (SAFE) score provided the greatest net benefit for predicting cirrhosis.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- How unarmed 911 teams are reshaping public safety in nearly 100 citiesContinue reading
- Menopause leaves a fingerprint that may predict dementia riskContinue reading
- Solving Alzheimer's with math? Researcher explores the possibilitiesContinue reading
- New brain tumor test could transform diagnosis and treatmentContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow